Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

20111,002 citationsJournal Articlegreen Open Access

Authors

Abstract

Elevated FGF-23 is an independent risk factor for end-stage renal disease in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease.

Topics & Keywords

Parathyroid Disorders and Treatments Biomedical Research and Pathophysiology Genetic Syndromes and Imprinting

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 305, Issue 23, pp. 2432-2432

DOI: 10.1001/jama.2011.826

Field-Weighted Citation Impact: 45.64